Category Archives: TDOC

Teladoc Health (NYSE: TDOC) announced its 2022 Q4 financial results on February 22, 2023. According to the announcement, total revenue was up 15% (YoY, 3 months). In addition, adjusted EBITDA was up 22% (YoY, 3 months). Teladoc recorded 3,773 million USD non-cash goodwill impairment in this quarter. As a result, operating loss and net lossContinue reading “Teladoc’s BetterHelp Playing Program recorded Adjusted EBITDA Margin of 19.1% “

Teladoc Health (NYSE: TDOC) announced its 2022 Q3 financial results on October 26, 2022. According to the announcement, total revenue was up 17% (YoY, 3 months). On the other hand, loss from operations and net loss totaled USD 71.7 million and USD 73.5 million, respectively (3 months). In addition, adjusted EBITDA was down 24% (YoY,Continue reading “Teladoc’s Net Loss totaled USD 73.5 Million in 2022 Q3”

Teladoc Health, Inc. (NYSE: TDOC) announced its 2022 Q2 financial results on July 27, 2022. According to the announcement, total revenue was up 18% (YoY, 3 months). On the other hand, Teladoc recorded operating loss and net loss of -3 billion USD each (3 months), due to non-cash goodwill impairment charge, which is related toContinue reading “Teladoc recorded Non-Cash Goodwill Impairment of 3.0 billion USD again”

Teladoc Health (NYSE: TDOC) announced its 2022 Q1 financial results on April 27, 2022. According to the announcement, total revenue was 565 million USD, up 25% (YoY, 3 months). Meanwhile, Teladoc recorded an operating loss of 6.7 billion USD and a net loss of 6.7 billion USD. These losses were primarily driven by non-cash goodwill impairmentContinue reading “Teladoc recorded 6.6 billion USD Goodwill Impairment Charge”

Teladoc Health (NYSE: TDOC) announced 2021 Q4 financial results on February 22nd, 2022. According to the announcement, revenue and adjusted EBITDA were up 45% and 53%, respectively (YoY, 3 months).  In this regard, the loss from operation was 41,429 thousand USD in 2021 Q4 compared to 458,506 thousand USD in 2020 Q4. Net loss wasContinue reading “Teladoc recorded Positive Free Cash Flow in Full Year of 2021”

Teladoc Health (NYSE: TDOC) announced its 2021 Q3 financial results on October 27, 2021. According to the announcement, total revenue was up 108% (9 months, YoY). Among them, subscription-based Access Fees revenue was up 133%. In addition, the other revenues, including that for chronic care, were up 177%. On the other hand, Teladoc recorded upContinue reading “Teladoc showed Strong Growth in its Acquired Business”

As many people know, Teladoc Health’s stock price had fallen by more than 50% since it hit a record high on February 7, 2021. What is behind the recent fall in stock price of Teladoc, which has been rumored to be a promising stock in the future? One reason for the stock price stagnation isContinue reading “What’s Teladoc’s Future after Acquisition of Livongo”

Teladoc Health (NYSE: TDOC) announced its 2021 Q2 financial results on July 27th.  According to the announcement, total revenue was up 109% (YoY, 3 months). However, Teladoc recorded operating loss and net loss of 78.9 million USD and 133.8 million USD, respectively.  In this regard, these amounts of operating loss and net loss were mainlyContinue reading “Teladoc recorded Positive Cash Flow in 2021 Q2”

Teladoc Health (NYSE: TDOC) announced its 2021 Q1 earning results on April 28th, 2021. According to the announcement, its total revenue showed significant growth of 151% (YoY, 3 months). In this regard, subscription-based access fee revenue was up 183% and visit fee revenue was up 24% (YoY, 3 months). In addition, U.S. paid membership wasContinue reading “Teladoc recorded 151% Growth in Its Total Revenue”

Teladoc Health (NYSE: TDOC) announced its 2020 Q4 earning results and annual results on February 24th. Although Teladoc recorded net loss of 485 million USD, total revenue was up 145% in 2020 Q4, and up 98% in twelve months (YoY). Subscription based access fee revenue was up 149% in Q4 and up 86% in twelve months.Continue reading “Teladoc Health recorded Net Loss of 485 Million USD”